# Walnut Cognition Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/walnut-cognition-meta-analysis-evidence-review
Category: evidence-review
Summary: Walnut Cognition Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed bi
Last reviewed: 2026-07-05
Reviewed by: Migaku Evidence Review
# Walnut Cognition Meta-analysis: What the Evidence Says

## Quick Answer

Walnut Cognition Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 preclinical study, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Brain Foods: A Narrative Review of Food Items and Their Impact on Cognition over the Life Course | preclinical study | 4 | 2026-05-31 | 10.3390/nu18111779 |
| Sustained visceral fat loss is associated with attenuated brain atrophy and improved cognitive function in late midlife | research article | 4 | 2026-03-26 | 10.1038/s41467-026-71141-4 |

## What The Sources Report

- With the global population aging, the prevalence of impairment and neurocognitive disorders has increased substantially, intensifying public health concerns. [Hardaway Chante (2026); evidence level 4]
- Among these, nutrition has emerged as a central and potentially scalable factor, with converging evidence suggesting that dietary exposures meaningfully influence brain structure, function, and long-term cognitive trajectories. [Hardaway Chante (2026); evidence level 4]
- Despite robust observational evidence, there is a limited understanding of whether long-term exposure to lower visceral adiposity, independent of weight loss, can attenuate brain atrophy and protect cognitive function over time. [Pachter Dafna (2026); evidence level 4]
- In the model including WM, VAT again demonstrated a negative effect ( = −0.5, = 0.004), while WM was positively associated ( = 0.42, = 0.012). [Pachter Dafna (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For walnut cognition meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Hardaway Chante (2026). Brain Foods: A Narrative Review of Food Items and Their Impact on Cognition over the Life Course. DOI: 10.3390/nu18111779. PMCID: PMC13258466. PMID: 42280422. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13258466/
- Pachter Dafna (2026). Sustained visceral fat loss is associated with attenuated brain atrophy and improved cognitive function in late midlife. DOI: 10.1038/s41467-026-71141-4. PMCID: PMC13183986. PMID: 41888134. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13183986/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.